$110 Million is the total value of Darwin Global Management, Ltd.'s 1 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 92.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AZN | Buy | ASTRAZENECA PLCsponsored adr | $110,236,000 | +269.7% | 1,661,684 | +224.6% | 100.00% | +2095.4% |
VERV | Exit | VERVE THERAPEUTICS INC | $0 | – | -23,104 | -100.0% | -0.13% | – |
ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -216,143 | -100.0% | -0.48% | – |
FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -317,428 | -100.0% | -0.86% | – |
CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -161,802 | -100.0% | -0.90% | – |
VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -145,841 | -100.0% | -0.93% | – |
KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -111,500 | -100.0% | -1.00% | – |
FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -153,537 | -100.0% | -1.37% | – |
ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -166,190 | -100.0% | -1.90% | – |
BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -90,057 | -100.0% | -3.55% | – |
INBX | Exit | INHIBRX INC | $0 | – | -591,975 | -100.0% | -3.95% | – |
NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -605,587 | -100.0% | -10.94% | – |
PFE | Exit | PFIZER INC | $0 | – | -7,697,762 | -100.0% | -69.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FATE THERAPEUTICS INC | 5 | Q4 2021 | 24.2% |
KEROS THERAPEUTICS INC | 5 | Q1 2023 | 12.8% |
INHIBRX INC | 5 | Q4 2021 | 3.9% |
ACCELERON PHARMA INC | 4 | Q3 2021 | 63.4% |
AMBRX BIOPHARMA INC | 4 | Q3 2023 | 67.5% |
ARGENX SE | 4 | Q3 2023 | 70.2% |
BRIDGEBIO PHARMA INC | 4 | Q3 2021 | 25.2% |
FULCRUM THERAPEUTICS INC | 4 | Q4 2021 | 0.9% |
ASTRAZENECA PLC | 3 | Q2 2022 | 100.0% |
INTELLIA THERAPEUTICS INC | 3 | Q4 2021 | 48.6% |
View Darwin Global Management, Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
4 | 2023-06-28 |
SC 13D/A | 2023-06-28 |
SC 13D/A | 2023-05-25 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-03 |
3 | 2023-03-08 |
View Darwin Global Management, Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.